Andrew Galler
Stock Analyst at Morgan Stanley
(0.58)
# 3,962
Out of 4,944 analysts
29
Total ratings
33.33%
Success rate
-15.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Equal-Weight | $35 | $33.00 | +6.06% | 13 | Mar 7, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $7.19 | +108.62% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $5.85 | +207.69% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $19.99 | +85.09% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $43.10 | +29.93% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $4.57 | +293.87% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $48.17 | +12.10% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $65.13 | -23.23% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.09 | +1,323.95% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $26.89 | +1,030.53% | 1 | Nov 9, 2021 |
Immunocore Holdings
Mar 7, 2025
Assumes: Equal-Weight
Price Target: $35
Current: $33.00
Upside: +6.06%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $7.19
Upside: +108.62%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $5.85
Upside: +207.69%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $19.99
Upside: +85.09%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $43.10
Upside: +29.93%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $4.57
Upside: +293.87%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $48.17
Upside: +12.10%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $65.13
Upside: -23.23%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.09
Upside: +1,323.95%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $26.89
Upside: +1,030.53%